XOMA Corp financial data

Symbol
XOMA, XOMAO, XOMAP on Nasdaq
Industry
Pharmaceutical Preparations
Location
2200 Powell Street, Suite 310, Emeryville, California
Fiscal year end
December 31
Former names
XOMA LTD /DE/ (to 1/17/2012), XOMA CORP /DE/ (to 3/19/1998)
Latest financial report
10-Q - Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 742 % -16.5%
Debt-to-equity 81.7 % +483%
Return On Equity -40.9 % -109%
Return On Assets -22.5 % -31.3%
Operating Margin -666 % +12.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11.6 M shares +1.44%
Common Stock, Shares, Outstanding 11.6 M shares +1.53%
Entity Public Float 124 M USD -19.9%
Common Stock, Value, Issued 87 K USD +1.16%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 5.81 M USD +73.1%
Revenue from Contract with Customer, Excluding Assessed Tax 1 M USD
Research and Development Expense 122 K USD -19.2%
General and Administrative Expense 27.9 M USD +14.8%
Operating Income (Loss) -38.7 M USD -51.6%
Net Income (Loss) Attributable to Parent -39.6 M USD -60.8%
Earnings Per Share, Basic -3.92 USD/shares -48.5%
Earnings Per Share, Diluted -3.92 USD/shares -48.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 136 M USD +208%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 147 M USD +226%
Property, Plant and Equipment, Net 40 K USD +567%
Operating Lease, Right-of-Use Asset 364 K USD +443%
Intangible Assets, Net (Excluding Goodwill) 14.5 M USD
Other Assets, Noncurrent 533 K USD +105%
Assets 219 M USD +64.2%
Accounts Payable, Current 1.52 M USD +247%
Liabilities, Current 15.5 M USD +54%
Operating Lease, Liability, Noncurrent 319 K USD
Liabilities 137 M USD +616%
Retained Earnings (Accumulated Deficit) -1.23 B USD -3.32%
Stockholders' Equity Attributable to Parent 82.3 M USD -28.1%
Liabilities and Equity 219 M USD +64.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.95 M USD -0.47%
Net Cash Provided by (Used in) Financing Activities -4.96 M USD -262%
Net Cash Provided by (Used in) Investing Activities -7.25 M USD -0.17%
Common Stock, Shares Authorized 277 M shares 0%
Common Stock, Shares, Issued 11.6 M shares +1.53%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -17.1 M USD -26.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 142 M USD +221%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.78 M USD
Deferred Tax Assets, Valuation Allowance 58.3 M USD +15.9%
Deferred Tax Assets, Gross 58.3 M USD +15.9%
Operating Lease, Liability 374 K USD -99.5%
Payments to Acquire Property, Plant, and Equipment 17 K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -39.6 M USD -60.8%
Lessee, Operating Lease, Liability, to be Paid 462 K USD
Operating Lease, Liability, Current 55 K USD -20.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 88 K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 85 K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +54.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 88 K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 91 K USD
Deferred Tax Assets, Operating Loss Carryforwards 30.1 M USD +25.7%
Preferred Stock, Shares Authorized 1 M shares 0%
Unrecognized Tax Benefits 5.9 M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 102 K USD
Operating Lease, Payments 23 K USD -55.8%
Additional Paid in Capital 1.31 B USD +0.57%
Amortization of Intangible Assets 897 K USD
Share-based Payment Arrangement, Expense 4.34 M USD -14.3%
Preferred Stock, Par or Stated Value Per Share 0.05 USD/shares 0%